Recursion Pharmaceuticals (RXRX) saw a sharp uptick in trading as investors looked ahead to the CEO's upcoming presentation at a major AI conference. The focus is on how the company’s AI strategy and ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage ...

We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on Emil Hartela Investing’s Substack by Emil. In this ...

A Python visualizer is a tool that shows you how your code runs, step by step, using pictures and diagrams. It helps you see ...

In crypto, real gains don’t happen when the spotlight is at full strength. They happen in the quiet moments, when something ...

In crypto, real fortunes are made not when everyone is piling in but when something powerful is just beginning to move. Right now, Zero Knowledge Proof (ZKP) sits at that exact point, a moment when ...

For one thing, BigBear.ai's revenue plunged 18% year over year in the second quarter of 2025. While Diebold Nixdorf's revenue also fell, the decline was only 2.6%. Importantly, the company's revenue ...